Sewage workers with low antibody responses may be colonized successively by several Tropheryma whipplei strains  by Fenollar, Florence et al.
International Journal of Infectious Diseases 35 (2015) 51–55Sewage workers with low antibody responses may be colonized
successively by several Tropheryma whipplei strains
Florence Fenollar a, Thomas Marth b, Jean-Christophe Lagier a, Emmanouil Angelakis a,
Didier Raoult a,*
aAix-Marseille Universite´, Unite´ de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE) UM63, CNRS 7278, IRD 198, Inserm 1095,
13005 Marseille, France
bAbteilung Innere Medizin, Krankenhaus Maria Hilf, Daun, Germany
A R T I C L E I N F O
Article history:
Received 16 March 2015
Received in revised form 13 April 2015
Accepted 15 April 2015
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark.
Keywords:
Tropheryma whipplei
Sewage workers
Asymptomatic carriage
Whipple’s disease
S U M M A R Y
Objectives: Asymptomatic faecal carriage of Tropheryma whipplei, the agent of Whipple’s disease, is
reported among sewage workers. However, the potential development of such carriage is unknown. A 7-
year follow-up of T. whipplei-carrying sewage workers is reported.
Methods: Nineteen sewage workers previously detected as faecal carriers of T. whipplei were followed to
ascertain the chronicity of their carriage. Faeces were tested by molecular assays using quantitative real-
time PCR speciﬁcally targeting T. whipplei. Serological anti-T. whipplei Western blotting was also
performed.
Results: Seventy-nine percent (15/19) of workers exhibited a strong immune response against T.
whipplei. Among these, ﬁve were followed for more than 1 year. Four maintained a strong response, with
three carrying the same strain and one becoming negative. The ﬁfth exhibited a decreased immune
response, a negative faeces result, and subsequent carriage of another strain. Three individuals with low
immune responses were also followed. Two never developed a response, with one carrying the same
strain and one becoming negative and then positive with another strain; the third developed a strong
response and became negative.
Conclusions: Chronic T. whipplei carriers appear to be protected against reinfection, but those with low or
decreasing antibody levels may be re-colonized by another strain.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Tropheryma whipplei, the causative agent of Whipple’s disease,
can cause numerous clinical problems. Chronic infections include
classic Whipple’s disease, which is disseminated and is deﬁned by
small-bowel biopsy involvement, and localized infections such as
endocarditis, encephalitis, uveitis, or arthritis.1–5 T. whipplei has
also been associated with acute infections, including gastroenteri-
tis, pneumonia, and bacteraemia, which likely correspond to a
primary infection.3,6–8 The natural history of classic Whipple’s
disease remains poorly understood because T. whipplei is a
common bacterium,9,10 and in contrast, Whipple’s disease and T.
whipplei infections are rarely reported.2,11* Corresponding author. Tel.: +33 4 91 32 43 75; fax: +33 4 91 38 77 72.
E-mail address: didier.raoult@gmail.com (D. Raoult).
http://dx.doi.org/10.1016/j.ijid.2015.04.009
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Asymptomatic stool carriage of T. whipplei has been detected in
humans, with varying prevalence depending on age, geographic
area, and exposure.9,12 In France, the prevalence is higher among
sewage workers (12–26%) and homeless people (13%) than in the
general adult population (4%).12–14 In rural Senegal, the prevalence
is 17% for adults and reaches 75% in children less than 5 years
old;15 the prevalence in rural Gabon is 9.7% for adults and reaches
40% in children less than 5 years old.16 Furthermore, T. whipplei
prevalence reaches 38% among relatives of French patients with
Whipple’s disease or chronic carriers.14 In addition, the seroprev-
alence of T. whipplei has been estimated at 50% in France, 73% in
rural Senegal, and 77% among French relatives of patients or
chronic carriers.14,15
As Whipple’s disease has not been reported, for example, in
sewage workers or homeless people, and is very rarely reported in
individuals of African descent, the group with the highest
T. whipplei exposure rate, it has to be assumed that additionalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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bacterium to systemic Whipple’s disease.9 The pathogenetic
factors are most likely host-related, and a rather weak HLA
association and subtle defects of the mucosal immune system have
been described in patients with classic Whipple’s disease.17–19
However, it remains unclear why this should be sufﬁcient to
accelerate T. whipplei infection. Thus, as described in the recent
literature, medical immunosuppression initiated in patients with
unclear arthritis2,20,21 may exacerbate T. whipplei infection in some
individuals. Western blot serology performed in patients with
classic Whipple’s disease generally shows that these patients have
low immune reactivity, whereas asymptomatic carriers typically
develop a strong immune response against T. whipplei.22 Finally,
despite the apparent clearance of T. whipplei in Whipple’s disease
patients following antibiotic treatment, reinfections with a new
genotype have been observed.3,23
These epidemiological, clinical, and biological ﬁndings regard-
ing T. whipplei suggest that host factors play a key role in the
pathogenesis of Whipple’s disease.1,9 Some recent evidence also
suggests that it could have a genetic basis.24 Furthermore, although
most cases do not result in clinical involvement, these results
explain why a unique bacterium can cause a potentially fatal
disease. The clinical and biological follow-up of a French cohort of
asymptomatic sewage worker carriers is reported here.
2. Patients and methods
2.1. Individuals
Nineteen sewage workers were detected as carriers of T.
whipplei during a faecal survey among the staff working with
sewage in Marseille, France.12 When carriage was detected during
the screening survey, the patients were invited to a specialized
consultation with one of the authors (DR) to evaluate the
chronicity of their carriage, the potential presence of clinical
manifestations, and the presence of an immune response against T.
whipplei. Depending on the individual, they were followed at two
specialized consultations and underwent one clinical examination
per year. It was not possible to take a duodenal biopsy from these
workers. This study was approved by the local ethics committee.
All participants gave written informed consent.
2.2. Molecular assays
DNA was extracted from stool or saliva samples using Qiagen
columns (QIAamp DNA kit; Qiagen, Courtaboeuf, France) in
accordance with the manufacturer’s recommendations. The
samples were handled under sterile conditions to avoid cross-
contamination. A speciﬁc quantitative real-time PCR (qPCR) assay
using speciﬁc oligonucleotide TaqMan probes to target T. whipplei
repeated sequences was performed to detect DNA from this
bacterium in the specimens, as described previously.25 A case was
deﬁned as positive if two independent qPCR assays targeting
different repeated sequences were positive, with cycle threshold
(Ct) values of <35. The T. whipplei strain Marseille-Twist was used
as a positive control and PCR mixes were used as a negative control.
The human b-actin gene was detected systematically in parallel to
check the quality of the extracted DNA.26
2.3. Genotyping
Genotyping was performed on stool samples positive for T.
whipplei using a multi-spacer system, as described previously.27
Each of the four highly variable genomic sequences (HVGSs)
obtained from each specimen were compared to those available inboth the GenBank database and our internal laboratory database to
determine the corresponding genotype.23,27
2.4. Western blot serology
Serological assays were performed by Western blotting. Native
and deglycosylated proteins were prepared, separated by sodium
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE),
and transferred onto nitrocellulose membranes, as described
previously.22 The membranes were incubated with primary sera,
washed, and then incubated with a peroxidase-conjugated goat
anti-human antibody (Southern Biotech, Birmingham, AL, USA), as
described previously. Detection was performed using chemilumi-
nescence (Enhanced Chemiluminescence Western Blotting Analy-
sis System; Amersham Biosciences, Uppsala, Sweden) with an
automated ﬁlm processor (Hyperprocessor; GE Healthcare, Ve´lizy-
Villacoublay, France). The ﬁlms were scanned with Image Scanner
III (GE Healthcare). Image analysis was performed with GelEval
1.21b FrogDance software and ImageJ 1.39 v software (Wayne
Rasband, National Institutes of Health) in order to quantify the
signal of the bands on the Western blots, and interpretation was
performed as reported previously.22
3. Results
3.1. Individuals
All 19 sewage carriers were seen for their ﬁrst specialized
consultation and were also seen by a physician at each of their
follow-up consultations. None of the sewage workers presented
clinical manifestations (arthralgia, diarrhoea, or weight loss) at the
time of the ﬁrst consultation or during the follow-up period.
3.2. First consultation
The data from the ﬁrst consultation are summarized in
Table 1. Western blot serology showed that 15 of 19 (79%) sewage
workers exhibited a strong immune response against T. whipplei,
whereas four (21%) had a low or absent immune response. Among
the 15 individuals with a strong immune response, PCR for T.
whipplei in faeces and saliva was negative in four individuals
(26.7%). Eleven of the 15 (73.3%) patients with a strong response
were still positive for T. whipplei in faeces, including two (13.3%)
who were also carriers of T. whipplei in saliva. Among the four
patients with a low immune response, three were positive for T.
whipplei in faeces but not saliva. One was negative in both saliva
and faeces.
3.3. Follow-up period
The data from the follow-up consultations are summarized in
Table 1. Among the four individuals with a low immune response,
one individual (SW1) never developed an immune response
against T. whipplei; he always carried the same T. whipplei strain,
genotype 36, in his faeces for the entire 6-year follow-up and was
also a saliva carrier. Another individual (SW2) never developed an
immune response against T. whipplei during the 2-year follow-up
and was alternately faeces positive and negative for T.
whipplei. Two different T. whipplei strains were detected; he ﬁrst
carried genotype 119 and then carried genotype 11 after PCR had
become negative. Another individual (SW3) developed protective
immunity against this T. whipplei strain, as his faeces became
negative for T. whipplei; during the second year of follow-up, the
faeces were still negative for T. whipplei, but a decreased immune
response was observed. The last individual (SW4) was lost to
follow-up after 1 year.
Table 1
Summary of the follow-up of 19 sewage worker carriers of Tropheryma whipplei
F. Fenollar et al. / International Journal of Infectious Diseases 35 (2015) 51–55 53
genotype 08
genotype 40
genotype 82
genotype 01
genotype 43
genotype 45
genotype 09
genotype 28
genotype 35
genotype 30
genotype 27
genotype 39
genotype 16
genotype 42
genotype 03
genotype 29
genotype 38
genotype 32
genotype 36
genotype 11
genotype 33
genotype 59
genotype 26
genotype 44
genotype 41
genotype 97
genotype 90
genotype 11988
86
86
97
88
61
40
55
70
49
63
71
61
45
57
44
74
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58
61
41
54
65
Sewage worker 1 
Sewage worker 2 
Sewage workers 3 and 4 
Sewage worker 5 
Sewage worker 5 
Sewage worker 6 
Sewage worker 6 
Figure 1. Neighbour-joining tree of Tropheryma whipplei genotypes; arrows indicate
genotypes found among sewage workers.
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were followed for more than 1 year. Among these, four individuals
exhibited a strong immune response during the entire follow-up.
At 2 years of follow-up, one individual became faeces-negative,
whereas three were always positive for T. whipplei. They all carried
the same strain as that present at the time of the ﬁrst detection
(genotype 82 for SW6 and genotype 39 for SW7 and SW8). In
particular, SW6 carried genotype 82 for 7 years. For the last
individual (SW5), a decreased immune response and negativity of
the faeces were observed after the ﬁrst year. The second year, the
faeces were again positive for T. whipplei, but with a different strain
(genotype 90) to that initially detected (genotype 29). Unfortu-
nately, contact with this patient was lost and a serum sample was
not obtained for testing by Western blotting when he was a carrier
of the new genotype. A dendrogram showing the phylogenetic
organization of the genotypes is presented in Figure 1.
4. Discussion
A high prevalence of T. whipplei among sewage workers in
Marseille, France has been found previously.12 The study presented
here conﬁrms that sewage workers can be asymptomatic carriers
of T. whipplei for years. Indeed, none of the T. whipplei-positive
workers tested had classic clinical manifestations of Whipple’s
disease, such as arthralgia or chronic diarrhea.2 We believe that
these ﬁndings are reliable because each positive result was
conﬁrmed by the ampliﬁcation of a second T. whipplei-speciﬁc
sequence, and the DNA extraction quality, including the presence
of inhibitors, was examined for all samples analyzed.25 Moreover,
the systematic analysis of negative controls yielded the expected
results.Although a high prevalence of asymptomatic carriage of T.
whipplei has been observed previously in sewage workers,
homeless people, people living in rural Africa, and relatives of
patients or T. whipplei carriers, this follow-up analysis provides the
ﬁrst evidence that asymptomatic carriage of T. whipplei can be
chronic.16,28 The longest carriage of the same strain was 7 years.
This study also conﬁrmed that all the asymptomatic carriers with
PCR-positive saliva specimens also harboured T. whipplei in their
faeces.
In this study, it was found for the ﬁrst time that chronic T.
whipplei carriers can be colonized by different T. whipplei strains
over time. Overall, genotyping has shown a high genetic diversity
of T. whipplei; in contrast, clinical signs are not related to speciﬁc T.
whipplei strains.9,12,27,29 A high genetic diversity among the T.
whipplei isolates recovered from sewage workers was also
observed. Thus, no clonal T. whipplei strain was detected among
sewage workers, although this has been reported for homeless
people (a potential epidemic clone was detected) and family
members (intrafamilial circulation of a single clone has been
observed).28 This may be linked to the mode of contamination,
including direct human contact for homeless people or relatives
and indirect human contact through faeces and sewage for sewage
workers (epidemic versus endemic).
None of the chronic carriers followed for more than 1 year and
who exhibited a strong immune response to T. whipplei throughout
the follow-up period was reinfected by another T. whipplei
genotype. In contrast, among three carriers who presented a
low immune response, two were carriers of two different T.
whipplei strains. Each of these individuals was PCR-negative for T.
whipplei in their faeces prior to the detection of a new strain. These
results indicate the signiﬁcance of different immune responses
among asymptomatic carriers.14,22 The low immune reactivity of
the two carriers likely allowed reinfection by another T. whipplei
strain, as already reported for Whipple’s disease patients who were
cured prior to being reinfected with another strain.23,30 Another
previously suggested hypothesis is that chronic T. whipplei carriers
are colonized by different T. whipplei strains, with one strain
becoming dominant.12 Another hypothesis is that such individuals
are only able to produce a strain-speciﬁc immune response, which
is comparable to what has already been observed for giardiasis,
with partial protective immunity.31,32
Finally, T. whipplei is a bacterium that is associated with an
underestimated number of acute clinical manifestations. The
working conditions of sewage workers directly in contact with
stool may explain the high prevalence of T. whipplei among this
population. We also found that chronic asymptomatic carriers of T.
whipplei can present different immune responses against T.
whipplei.
In conclusion, chronic carriers of T. whipplei are apparently
protected against reinfection, but those with low or decreasing
antibody levels may be re-colonized by another T. whipplei strain.
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